Advanced search×

Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy.

R Hachamovitch, A Rozanski, L J Shaw, G W Stone, L E J Thomson, J D Friedman, S W Hayes, I Cohen, G Germano, and D S Berman

Eur Heart J 32(8):1012-24 (2011) PMID 21258084

Although pre-revascularization ischaemia testing is recommended, the interaction between the extent of ischaemia and myocardial scar with performance of revascularization on patient survival is unclear.

DOI: 10.1093/eurheartj/ehq500
Version: za2963e q8za3 q8zb9 q8zc8 q8zd0 q8zef q8zff q8zg6
Buy PDF

Similar articles you may find interesting…

  1. Inhaled Carbon Monoxide Accelerates Resolution of Inflammation via Unique Proresolving Mediator-Heme Oxygenase-1 Circuits.
    Nan Chiang, Masakazu Shinohara, and Charles N Serhan

    J Immunol (2013) PMID 23650615

    We employed a systems approach to determine the impact of CO in resolution active programs during self-limited inflammation in mice. Compared with ambient air, inhaled CO gas (250 ppm) significantly limited PMN infiltration (∼44%, 6 h) into peritoneum and shortened resolution interval from 4 to 2...
    Buy PDF
  2. Dosimetric impact of Acuros XB deterministic radiation transport algorithm for heterogeneous dose calculation in lung cancer.
    Tao Han, David Followill, and Firas Mourtada

    Med Phys 40(5):051710 (2013) PMID 23635258

    AXB is satisfactorily accurate for the dose calculation in lung cancer for both IMRT and VMAT plans. The differences between AXB and AAA are generally small except in heterogeneous interface regions. AXB Dw,m and Dm,m calculations are similar inside the soft tissue and lung regions. AXB can benefit...
    Buy PDF
  3. Cancer and Venous Thrombosis: Current Comprehensions and Future Perspectives.
    Mandy N Lauw, Frederiek F van Doormaal, and Harry R Buller

    Semin Thromb Hemost (2013) PMID 23629821

    Venous thromboembolism (VTE) is a common complication in all types of cancer and adversely impacts cancer prognosis. Randomized controlled trials with primary thromboprophylaxis in cancer patients generally show effective VTE relative risk reductions of up to 60%. However, absolute r...
    Buy PDF